161 related articles for article (PubMed ID: 26363413)
21. Effectiveness of antibacterial prophylaxis with non-absorbable polymyxin B compared to levofloxacin after allogeneic hematopoietic stem cell transplantation.
Koh S; Yamada K; Nishimoto M; Hayashi Y; Koh H; Nakashima Y; Nakane T; Hirose A; Nakamae M; Kakeya H; Hino M; Nakamae H
Transpl Infect Dis; 2015 Oct; 17(5):647-54. PubMed ID: 26134140
[TBL] [Abstract][Full Text] [Related]
22. Bacteremia during neutropenic episodes in children undergoing hematopoietic stem cell transplantation with ciprofloxacin and penicillin prophylaxis.
Choeyprasert W; Hongeng S; Anurathapan U; Pakakasama S
Int J Hematol; 2017 Feb; 105(2):213-220. PubMed ID: 27771837
[TBL] [Abstract][Full Text] [Related]
23. Early bacteremia in pediatric hematopoietic stem cell transplant patients on oral antibiotic prophylaxis.
Kersun LS; Propert KJ; Lautenbach E; Bunin N; Demichele A
Pediatr Blood Cancer; 2005 Aug; 45(2):162-9. PubMed ID: 15593235
[TBL] [Abstract][Full Text] [Related]
24. Colonization With Fluoroquinolone-Resistant Enterobacterales Decreases the Effectiveness of Fluoroquinolone Prophylaxis in Hematopoietic Cell Transplant Recipients.
Satlin MJ; Chen L; Douglass C; Hovan M; Davidson E; Soave R; La Spina M; Gomez-Arteaga A; van Besien K; Mayer S; Phillips A; Hsu JM; Malherbe R; Small CB; Jenkins SG; Westblade LF; Kreiswirth BN; Walsh TJ
Clin Infect Dis; 2021 Oct; 73(7):1257-1265. PubMed ID: 33956965
[TBL] [Abstract][Full Text] [Related]
25. The addition of doxycycline to fluoroquinolones for bacterial prophylaxis in autologous stem cell transplantation for multiple myeloma.
Guare EG; Hale CM; Sivik J; Lehman E; Inoue Y; Rakszawski K; Songdej N; Nickolich M; Zheng H; Naik S; Claxton D; Rybka W; Hohl R; Mineishi S; Minagawa K; Paules CI
Transpl Infect Dis; 2024 Apr; 26(2):e14241. PubMed ID: 38269469
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: A systematic review of randomized trials.
Egan G; Robinson PD; Martinez JPD; Alexander S; Ammann RA; Dupuis LL; Fisher BT; Lehrnbecher T; Phillips B; Cabral S; Tomlinson G; Sung L
Cancer Med; 2019 Aug; 8(10):4536-4546. PubMed ID: 31274245
[TBL] [Abstract][Full Text] [Related]
27. Levofloxacin Prophylaxis During Induction Therapy for Pediatric Acute Lymphoblastic Leukemia.
Wolf J; Tang L; Flynn PM; Pui CH; Gaur AH; Sun Y; Inaba H; Stewart T; Hayden RT; Hakim H; Jeha S
Clin Infect Dis; 2017 Nov; 65(11):1790-1798. PubMed ID: 29020310
[TBL] [Abstract][Full Text] [Related]
28. A comparison of levofloxacin and oral third-generation cephalosporins as antibacterial prophylaxis in acute leukaemia patients during chemotherapy-induced neutropenia.
Yemm KE; Barreto JN; Mara KC; Dierkhising RA; Gangat N; Tosh PK
J Antimicrob Chemother; 2018 Jan; 73(1):204-211. PubMed ID: 29040595
[TBL] [Abstract][Full Text] [Related]
29. Changes in the microbiological epidemiology of febrile neutropenia in autologous stem cell transplant recipients.
Rönkkö R; Juutilainen A; Koivula I; Vänskä M; Nousiainen T; Jantunen E; Hämäläinen S
Infect Dis (Lond); 2018 Jun; 50(6):436-442. PubMed ID: 29303041
[TBL] [Abstract][Full Text] [Related]
30. Blood stream infections after allogeneic stem cell transplantation: a single-center experience with the use of levofloxacin prophylaxis.
Busca A; Cavecchia I; Locatelli F; D'Ardia S; De Rosa FG; Marmont F; Ciccone G; Baldi I; Serra R; Gaido E; Falda M
Transpl Infect Dis; 2012 Feb; 14(1):40-8. PubMed ID: 21599817
[TBL] [Abstract][Full Text] [Related]
31. Obesity is not strongly associated with increased risk for febrile neutropenia during levofloxacin prophylaxis in patients with hematological malignancies receiving intermediate-risk myelosuppressive chemotherapy.
Kurtti A; Fritz K; Elofson-Disney K; Benefield R
J Oncol Pharm Pract; 2020 Sep; 26(6):1301-1305. PubMed ID: 31810423
[TBL] [Abstract][Full Text] [Related]
32. Bacteraemia post-autologous haematopoietic stem cell transplantation in the absence of antibacterial prophylaxis: a decade's experience from Lebanon.
Moghnieh R; Abdallah D; Awad L; Jisr T; Mugharbil A; Youssef A; Tamim H; Khaldieh S; Massri O; Rashini N; Hamdan Y; Ibrahim A
Infection; 2018 Dec; 46(6):823-835. PubMed ID: 30143988
[TBL] [Abstract][Full Text] [Related]
33. Prophylactic antibiotics for the prevention of neutropenic fever in patients undergoing autologous stem-cell transplantation: results of a single institution, randomized phase 2 trial.
Eleutherakis-Papaiakovou E; Kostis E; Migkou M; Christoulas D; Terpos E; Gavriatopoulou M; Roussou M; Bournakis E; Kastritis E; Efstathiou E; Dimopoulos MA; Papadimitriou CA
Am J Hematol; 2010 Nov; 85(11):863-7. PubMed ID: 20882526
[TBL] [Abstract][Full Text] [Related]
34. The impact of a change in antibacterial prophylaxis from ceftazidime to levofloxacin in allogeneic hematopoietic cell transplantation.
Guthrie KA; Yong M; Frieze D; Corey L; Fredricks DN
Bone Marrow Transplant; 2010 Apr; 45(4):675-81. PubMed ID: 19718062
[TBL] [Abstract][Full Text] [Related]
35. Levofloxacin for Antibacterial Prophylaxis in Pediatric Patients With Acute Myeloid Leukemia or Undergoing Hematopoietic Stem Cell Transplantation.
Patel B; Noda A; Godbout E; Stevens M; Noda C
J Pediatr Pharmacol Ther; 2020; 25(7):629-635. PubMed ID: 33041718
[TBL] [Abstract][Full Text] [Related]
36. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation.
Diaz MA; Vicent MG; Prudencio M; Rodriguez F; Marin C; Serrano A; Sevilla J; Casado J; Madero L
Haematologica; 2002 Mar; 87(3):292-8. PubMed ID: 11869942
[TBL] [Abstract][Full Text] [Related]
37. Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation.
Lehrnbecher T; Fisher BT; Phillips B; Alexander S; Ammann RA; Beauchemin M; Carlesse F; Castagnola E; Davis BL; Dupuis LL; Egan G; Groll AH; Haeusler GM; Santolaya M; Steinbach WJ; van de Wetering M; Wolf J; Cabral S; Robinson PD; Sung L
Clin Infect Dis; 2020 Jun; 71(1):226-236. PubMed ID: 31676904
[TBL] [Abstract][Full Text] [Related]
38. Prophylactic Use Of Levofloxacin During Induction Of Acute Lymphoblastic Leukaemia In Children-Experience From Pakistan.
Rehman P; Shaukat Z; Saeed H; Raza A; Anjum S; Wali RM
J Pak Med Assoc; 2023 Oct; 73(10):2065-2068. PubMed ID: 37876072
[TBL] [Abstract][Full Text] [Related]
39. Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Blennow O; Ljungman P; Sparrelid E; Mattsson J; Remberger M
Transpl Infect Dis; 2014 Feb; 16(1):106-14. PubMed ID: 24372809
[TBL] [Abstract][Full Text] [Related]
40. Efficacy of levofloxacin as an antibacterial prophylaxis for acute leukemia patients receiving intensive chemotherapy: a systematic review and meta-analysis.
Owattanapanich W; Chayakulkeeree M
Hematology; 2019 Dec; 24(1):362-368. PubMed ID: 30880638
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
